Log in to save to my catalogue

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype...

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2183640836

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

About this item

Full title

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

Publisher

Tokyo: Springer Japan

Journal title

Journal of gastroenterology, 2019-07, Vol.54 (7), p.641-649

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
Until recently, interferon-free anti-hepatitis C virus (HCV) therapy for genotype 2 (GT2) HCV-infected hemodialysis patients was an unfulfilled medical need. Recent clinical trials of glecaprevir and pibrentasvir (G/P) for hemodialysis patients showed high efficacy and safety; however, the number of GT2 HCV-infected patients, especial...

Alternative Titles

Full title

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2183640836

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2183640836

Other Identifiers

ISSN

0944-1174

E-ISSN

1435-5922

DOI

10.1007/s00535-019-01556-y

How to access this item